Scientists attribute this rise partly to increased exposure to ultraviolet (UV) radiation from the sun and tanning beds. Unlike most cancers, which predominantly affect older individuals, melanoma is also common in people under 30. Despite significant progress in treatment, many patients experience resistance to available therapies, making new approaches crucial.
2025
1 in 5 Patients Experience Skin Toxicity With Nivolumab/Relatlimab
In a study of patients with advanced melanoma, the prevalence of cutaneous immune–related adverse events (cirAEs) associated with nivolumab/relatlimab combination therapy was 21.5%, with rash and maculopapular eruption being most common.
Handheld Reflectance Confocal Microscopy Efficacious for Detecting Lentigo Maligna (Melanoma)
WEDNESDAY, March 5, 2025 (HealthDay News) — Handheld reflectance confocal microscopy (HH-RCM) is promising for detecting subclinical lentigo maligna (melanoma; LM/LMM), according to a study published in the March issue of the Journal of the European Academy of Dermatology & Venereology.
Dermatologists must be ‘actively involved’ in AI development to reduce disparities
ORLANDO — AI can transform how dermatologists diagnose skin conditions including melanoma; however, without attention to equitability, specifically in skin of color, it could exacerbate disparities in care, according to a speaker here.